LETTER: Aids discovery is largely irrelevant
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.From Mr James Deane
Sir: The discovery that a combination of therapies has been successful in treating people with Aids is exciting and encouraging (report, 26 September). It is largely irrelevant, however, to those with HIV and Aids in the developing world, where 90 per cent of all HIV infection is found.
The cost of treating one person for one year with the new combination of drugs is between pounds 3,000 and pounds 5,000. The annual per capita health budget of Malawi, for instance, where 10 per cent of the population is infected with HIV, is about pounds 3.
In developing countries, providing people with even the most basic drugs, such as aspirin, remains a problem. These countries need far more assistance to educate their publics and to establish health infrastructures, to help prevent the spread of Aids and provide care to those affected.
Sincerely
James Deane
Director, Aids Programme
Panos Institute
London N1
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments